Subscribe to MDT Magazine News

Tokyo Stock Exchange: morning price list -6-+

November 17, 2010 5:45 pm | by The Associated Press | Comments

TSEPrices UP/DN Nippon Meat Packers984 UP7 Nippon Paper Grp Inc 2021 UP 17 Nippon Sharyo Ltd368 UP5 Nippon Sheet Glass187 UP4 Nippon Shokubai Co784 UP1 Nippon Soda Co339 UP3 Nippon Steel Corp272 UP1 Nippon Suisan251 UP1 Nissan Chem Ind Ltd999 UP8 Nissan Motor Co787 DN7 Nisshin...

Summary Box: Medicare panel backs Provenge

November 17, 2010 1:45 pm | by The Associated Press | Comments

VOTE OF CONFIDENCE: Medicare advisers said they are confident in the benefits of Provenge, an innovative prostate cancer drug that has generated controversy because of its $93,000 price tag. Medicare will make a final decision on whether to pay for the drug in March.HURDLE CLEARED: The positive...

Structure of Lassa virus protein reveals viral thievery

November 17, 2010 11:40 am | by EurekAlert | Comments

(Emory University) Scientists have solved the structure of a key protein from Lassa virus, which is endemic to West Africa and can cause a deadly hemorrhagic fever. The structure reveals how the virus evades its host's immune system, and how it hijacks infected cells' vital...


HealthEdge Software rounds up $975K financing

November 17, 2010 11:39 am | by Mass High Tech: The Journal of New England Technology | Comments

HealthEdge Software Inc., a Burlington health-care software provider, has taken in $974,966 in a combination offering of equity and warrants, according to a filing with the U.S. Securities and Exchange Commission.

Forma collaborating with Eisai in $20M+ deal

November 17, 2010 11:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge small-molecule therapeutics developer Forma Therapeutics Inc. has signed a drug discovery collaboration agreement with Eisai Inc., the U.S. subsidiary of Tokyo pharmaceutical firm Eisai Co. Ltd.

Mortal chemical combat typifies the world of bacteria

November 17, 2010 9:42 am | by EurekAlert | Comments

(University of North Carolina School of Medicine) New research led by scientists from the University of North Carolina at Chapel Hill School of Medicine and the University of California, Santa Barbara, describes new complexities in the close chemical combat waged among bacteria....


AesRx gets NIH boost for sickle cell treatment

November 17, 2010 9:41 am | by Mass High Tech: The Journal of New England Technology | Comments

AesRx LLC, a sickle cell disease-focused biotech firm in Newton, is working with the National Institutes of Health to bring its treatment, Aes-103, designated an orphan drug by the FDA, to clinical trials.

New insight into dementia pathophysiology

November 17, 2010 8:38 am | by EurekAlert | Comments

(Cell Press) New research unravels a key molecular pathway underlying a neurodegenerative disorder that causes a devastating type of dementia. The study, published by Cell Press in the November 18 issue of the journal Neuron, sheds light on the pathological processing of...


Reportlinker Adds Global Uro-Gynecological Surgical Devices Industry

November 17, 2010 7:37 am | by Bio-Medicine.Org | Comments

NEW YORK, Nov. 17, 2010 /- announces that a new market research report is available in its catalogue: Global Uro-Gynecological Surgical Devices Industry This report analyzes the...


Encision's Active Electrode Monitoring Technology Recommended at Minimally Invasive Gynecology Congress

November 17, 2010 7:36 am | by Bio-Medicine.Org | Comments

BOULDER, Colo., Nov. 17, 2010 /- Active electrode monitoring developed and manufactured by Boulder-based Encision Inc. (Pink Sheets: ECIA ), is the only monopolar energy technology proposed as a solution to eliminate visceral burns during Single Port Laparoscopy according to a recent...


Fast Forward, LLC and Provid Pharmaceuticals Announce Expansion of their Partnership for the Development of PV-267, Provid's Unique MS Drug Candidate

November 17, 2010 7:36 am | by Bio-Medicine.Org | Comments

NEW YORK and NORTH BRUNSWICK, N.J., Nov. 17, 2010 /- Provid Pharmaceuticals, Inc , a drug discovery company, and Fast Forward, LLC , the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced an expansion of...


Recording Artist Danny Gokey to Donate Old Eyeglasses to Raise Funds for Free Eye Exams and Glasses for Needy Children

November 17, 2010 7:36 am | by Bio-Medicine.Org | Comments

GLENDALE, Wis., Nov. 17, 2010 /- Since early October hundreds of Danny Gokey fans have donated used eyeglasses and non-perishable food items at Wisconsin Vision stores throughout the state. In exchange for their donation, today those fans get to meet Gokey, the 19/RCA Nashville recording...


MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition

November 17, 2010 7:35 am | by Bio-Medicine.Org | Comments

GAITHERSBURG, Md., Nov. 17, 2010 /- MedImmune announced the winners of its 5th Annual Research Abstract Competition highlighting the work of the next generation of scientific leaders performing research in areas of respiratory, inflammation and autoimmune (RIA) disease. Graduate students...


Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test

November 17, 2010 7:34 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Nov. 17, 2010 /- Luminex Corporation (Nasdaq: LMNX ), today announced that it has commercially launched its first pharmacogenetic test, the xTAG® CYP2D6 Kit, which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The new test enables...


Minerva Biotech raises $4.6M

November 17, 2010 5:41 am | by Mass High Tech: The Journal of New England Technology | Comments

Minerva Biotechnologies Corp. has raised about $4.6 million of planned $5.9 million equity offering, in addition to warrants that could amount to $1.13 million more.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.